Worksheets[PHARM] Endo 1 GH drugs
Total questions: 18
Worksheet time: 10mins
• Recombinant human IGF-1
• Treatment of severe IGF-1 deficiency that is not responsive to GH
Mecasermine
Sermorelin acetate
Ocreotide
Lanreotide
Adverse effects of Mecasermine
Hypogylcemia
Hyperglycemia
Intracranial hypertension
Adenotonsillar hypertrophy
Increased SGPT & SGOT
What is the most common adverse effect of Mecasermine?
Hypoglycemia
Hyperglycemia
Intracranial hypertension
A carbohydrate-rich food or a snack is taken 20 minutes before/after administration of this drug
Mecasermine
Sermorelin acetate
Octreotide
Lanreotide
Complex of recombinant human IGF-1 (rhIGF-1) and recombinant human insulin-like growth factor binding protein- 3 (rhIGFBP-3)
Mecasermin rinfabate
Sermorelin acetate
• Synthetic GHRH
• Distinguish whether hypothalamic or pituitary deficiency
Mecasermine
Sermorelin acetate
Octreotide
Lanreotide
Synthetic analogs of somatostatin
Mecasermine
Sermorelin acetate
Octreotide
Lanreotide
- Most widely used somatostatin analog
- 45 times more potent than somatostatin in inhibiting GH release
Mecasermine
Octreotide
Lanreotide
Pegvisomant
- Half-life: 80 minutes (30x longer than somatostatin)
- Given 50-200mcg SC every 8 hours
Mecasermine
Octreotide
Lanreotide
Pegvisomant
Therapeutic Uses
- Treatment of Acromegaly
- Sever watery diarrhea (secretory and HIV associated)
- Flushing associated with carcinoid tumors
- Diabetes, Chemotherapy, or Radiation induced
- Portal Hypertension
- Acute control of bleeding esophageal varices
Mecasermine
Sermorelin acetate
Octreotide
Lanreotide
Adverse effects
- Diarrhea
- Abdominal pain
- Flatulence
- Nausea
- Steatorrhea w/ bulky bowel movements
Mecasermine
Octreotide
Lanreotide
Pegvisomant
Adverse effects
Cardiac effects
- Sinus bradycardia
- Conduction disturbance
Mecasermine
Sermorelin acetate
Octreotide
Lanreotide
Adverse effects
- Pain at site of infection
- Vitamin B12 deficiency
Mecasermine
Octreotide
Lanreotide
Pegvisomant
Adverse effects
Long-term use of Somatostatin, ___________, and __________ cause asymptomatic cholesterol gallstones
Mecasermine
Octreotide
Lanreotide
Pegvisomant
Octapeptide somatostatin analog approved for treatment of acromegaly
Mecasermine
Octreotide
Lanreotide
Pegvisomant
Growth Hormone receptor antagonist used to treat acromegaly
Mecasermine
Octreotide
Lanreotide
Pegvisomant
Does not inhibit GH secretion and may lead to increased GH levels and possible adenoma growth
Mecasermine
Octreotide
Lanreotide
Pegvisomant
Adverse effects
No serious problems have been observed however, increases in liver enzymes without liver failure have been reported.
Mecasermine
Octreotide
Lanreotide
Pegvisomant
